the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer
Official Title A Phase I Study of Stereotactic Body Radiation Therapy in Patients With Unresected Carcinoma of the Pancreas or Ampulla
Principal Investigator Liauw, Stanley
Brief Summary This purpose of this study is to determine the highest tolerated dose of Stereotactic Body Radiation Therapy (SBRT) and also to determine the appropriate dose for intact pancreatic cancer.
Gender Both
Ages 18 Years
Enrollment 24
Accepts Healthy Volunteers No
Lead Sponsor University of ChicagoOther
Collaborator
Study Design Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Study Phase Phase 1
Study Type Interventional
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Pancreatic Cancer
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI